Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

BACKGROUND: Patients with cancer have been shown to have a higher risk of clinical severity and mortality compared to non-cancer patients with COVID-19. Patients with hematologic malignancies typically are known to have higher levels of immunosuppression and may develop more severe respiratory viral...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Suárez, Julio, de la Cruz, Javier, Cedillo, Ángel, Llamas, Pilar, Duarte, Rafael, Jiménez-Yuste, Víctor, Hernández-Rivas, José Ángel, Gil-Manso, Rodrigo, Kwon, Mi, Sánchez-Godoy, Pedro, Martínez-Barranco, Pilar, Colás-Lahuerta, Blanca, Herrera, Pilar, Benito-Parra, Laurentino, Alegre, Adrián, Velasco, Alberto, Matilla, Arturo, Aláez-Usón, María Concepción, Martos-Martínez, Rafael, Martínez-Chamorro, Carmen, Susana-Quiroz, Keina, Del Campo, Juan Francisco, de la Fuente, Adolfo, Herráez, Regina, Pascual, Adriana, Gómez, Elvira, Pérez-Oteyza, Jaime, Ruiz, Elena, Alonso, Arancha, González-Medina, José, Martín-Buitrago, Lucía Núñez, Canales, Miguel, González-Gascón, Isabel, Vicente-Ayuso, María Carmen, Valenciano, Susana, Roa, María García, Monteliu, Pablo Estival, López-Jiménez, Javier, Escobar, Cristián Escolano, Ortiz-Martín, Javier, Diez-Martin, José Luis, Martinez-Lopez, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542567/
https://www.ncbi.nlm.nih.gov/pubmed/33032660
http://dx.doi.org/10.1186/s13045-020-00970-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542567/
https://www.ncbi.nlm.nih.gov/pubmed/33032660
http://dx.doi.org/10.1186/s13045-020-00970-7

Ejemplares similares